Monopar Therapeutics - COM NEW (MNPR)

Historical Portfolio Holders for Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
15.7K
Holdings value Q3 2024
$106K
Value change Q3 2024
+$106K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
6
Number of buys Q3 2024
6
Number of sells Q3 2024
0
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 15.7K $106K +$106K $6.74 6